ANA VALDES: Open Payments
NPI 1043799471 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,500 in 78 payments from 19 companies in 2025. Trend: 2023 $883 · 2024 $1,413 · 2025 $1,500
Food & beverage: $1,417Education: $83
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $387 |
| Ardelyx, Inc. | 11 | $169 |
| Lilly USA, LLC | 7 | $142 |
| Phathom Pharmaceuticals, Inc. | 9 | $137 |
| Janssen Biotech, Inc. | 4 | $116 |
| Regeneron Healthcare Solutions, Inc. | 3 | $88 |
| Madrigal Pharmaceuticals | 3 | $64 |
| VIVUS LLC | 3 | $63 |
| Novo Nordisk Inc | 2 | $55 |
| Ipsen Biopharmaceuticals, Inc | 2 | $53 |
Products named: LINZESS, IBSRELA, OMVOH, VOQUEZNA, TREMFYA, DUPIXENT, RINVOQ, REZDIFFRA.
Industry payments across FL — which companies pay providers there.
